|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0040808,
umls-concept:C0087111,
umls-concept:C0132326,
umls-concept:C0205174,
umls-concept:C0205265,
umls-concept:C0205466,
umls-concept:C0332256,
umls-concept:C0674428,
umls-concept:C1280519,
umls-concept:C1555582,
umls-concept:C1707455
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-2-2
|
|
pubmed:abstractText |
To compare outcomes of nonnucleoside reverse transcriptase inhibitors (NNRTIs) nevirapine or efavirenz versus abacavir-based regimens with a backbone of zidovudine and lamivudine as initial therapy of treatment-naive adults with HIV-1 infection in routine clinical care.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine,
http://linkedlifedata.com/resource/pubmed/chemical/Nevirapine,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazines,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir,
http://linkedlifedata.com/resource/pubmed/chemical/efavirenz
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
pubmed-author:AbrairaVíctorV,
pubmed-author:AntelaAntonioA,
pubmed-author:CasadoJosé LuisJL,
pubmed-author:DrondaFernandoF,
pubmed-author:GutiérrezCarolinaC,
pubmed-author:LópezDoloresD,
pubmed-author:MorenoAnaA,
pubmed-author:MorenoSantiagoS,
pubmed-author:NavasEnriqueE,
pubmed-author:Pérez-ElíasMaría JesúsMJ,
pubmed-author:QueredaCarmenC,
pubmed-author:RodríguezMiguel AngelMA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
312-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16452065-Adult,
pubmed-meshheading:16452065-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16452065-Benzoxazines,
pubmed-meshheading:16452065-CD4 Lymphocyte Count,
pubmed-meshheading:16452065-Cohort Studies,
pubmed-meshheading:16452065-Dideoxynucleosides,
pubmed-meshheading:16452065-Female,
pubmed-meshheading:16452065-HIV Infections,
pubmed-meshheading:16452065-HIV-1,
pubmed-meshheading:16452065-Humans,
pubmed-meshheading:16452065-Lamivudine,
pubmed-meshheading:16452065-Male,
pubmed-meshheading:16452065-Multivariate Analysis,
pubmed-meshheading:16452065-Nevirapine,
pubmed-meshheading:16452065-Oxazines,
pubmed-meshheading:16452065-Patient Compliance,
pubmed-meshheading:16452065-Prospective Studies,
pubmed-meshheading:16452065-RNA, Viral,
pubmed-meshheading:16452065-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16452065-Zidovudine
|
|
pubmed:articleTitle |
Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain. mjperez@telefonica.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
